A major national healthcare imperative for noninvasive imaging is for the tests that are used provide value. Nuclear cardiology, cardiac CT and cardiac MRI studies provide powerful tools for diagnosis, risk assessment, and guiding management of selected patients with known or suspected cardiac disease. In the current environment, imaging must address the combined considerations of improving outcomes and containing costs. To this end, advanced cardiac imaging studies must be ordered on the right ...